Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.93% | $21.00M | €367.93B | 41.71% | 76 Outperform | |
| AstraZeneca | 1.86% | $13.35M | £210.50B | 29.30% | 80 Outperform | |
| Roche Holding AG | 1.84% | $13.16M | CHF254.05B | 36.53% | 73 Outperform | |
| Novartis AG | 1.69% | $12.10M | CHF202.96B | 20.35% | 80 Outperform | |
| Nestlé SA | 1.66% | $11.90M | CHF197.97B | 14.43% | 71 Outperform | |
| SAP SE | 1.65% | $11.85M | €245.21B | -13.16% | 66 Neutral | |
| HSBC Holdings | 1.64% | $11.72M | HK$1.89T | 42.40% | 80 Outperform | |
| Shell (UK) | 1.43% | $10.21M | £157.23B | 8.40% | 73 Outperform | |
| Siemens | 1.36% | $9.76M | €183.54B | 20.44% | 74 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 1.22% | $8.75M | €310.78B | -3.40% | 78 Outperform |